[view original post] Many investors are looking to get rich quick, but the savvy among us realize that it’s not likely to happen. Worse,
Latest News
Latest News
Materials Weekly Round-up: TMC soars as nickel prices surge; aluminum stocks among losers
[view original post] Javier Ruiz/iStock via Getty Images The S&P Materials Select Sector Index closed -0.37% for the week, while the Materials Select Sector
2 Stocks To Buy Next Week As Listed By Sharekhan
[view original post] For Quick Alerts Subscribe Now For Quick Alerts ALLOW NOTIFICATIONS For Daily Alerts Personal Finance oi-Sunil Fernandes | Published:
Things To Consider Before You Buy CareDx Inc (NASDAQ: CDNA)
[view original post]CareDx Inc (NASDAQ:CDNA) shares, rose in value on Friday, 03/11/22, with the stock price down by -10.70% to the previous day’s close
Quantum Corporation (NASDAQ: QMCO) Forecast: Expect A -300.0% Drop Within A Few Months
[view original post]Quantum Corporation (NASDAQ:QMCO) shares, rose in value on Friday, 03/11/22, with the stock price down by -5.30% to the previous day’s close
Marqeta (NASDAQ:MQ) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
[view original post]Marqeta (NASDAQ:MQ – Get Rating) released its earnings results on Wednesday. The company reported ($0.07) EPS for the quarter, topping the consensus
Palo Alto Networks, Inc. (NASDAQ:PANW) Receives $611.34 Average PT from Brokerages
[view original post]Shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Get Rating) have earned an average recommendation of “Buy” from the thirty-four ratings firms
Adam Kinzinger: Zelensky 'Three Times the Man' Trump, Cawthorn Are Combined
[view original post][unable to retrieve full-text content]Representative Adam Kinzinger, an Illinois Republican, took aim at former President Donald Trump and GOP Representative Madison Cawthorn
Nervous About Stagflation? Buy These 2 Growth Stocks
[view original post] With crude oil prices sharply rising over the last few weeks and inflation hitting a 40-year high, it’s no wonder why
Design Therapeutics (NASDAQ:DSGN) Posts Earnings Results, Beats Expectations By $0.03 EPS
[view original post]Design Therapeutics (NASDAQ:DSGN – Get Rating) posted its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the